CLINICAL_TRIALS
trial_result
· 2016-04-04
Clinical Trial Update: Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024) [Phase 3]
Summary
Phase 3 trial update evaluating efficacy, safety, and immunogenicity of V260 in healthy infants for rotavirus gastroenteritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Gastroenteritis | Phase 3 | Status: COMPLETED | Results posted: 2016-04-04